tirzepatide is what brand name FDA approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an estimated price Eli Lilly is calling tirzepatide,

While pharmaceutical GLP-1 receptor agonists provide potent therapeutic effects, several evidence-based lifestyle and dietary strategies may support endogenous GLP-1 secretion

Compounded GLP-1 medications have limited insurance coverage compared to branded options

Incorporating salt and electrolytes into the diet can significantly alleviate dizziness associated with semaglutide, especially when gastrointestinal side effects such as nausea or vomiting lead to dehydration

In contrast, the occurrence of vomiting and diarrhea did not show significant differences between the two groups

Persistent hoarseness

Persistent nausea lasting more than 2 weeks after a dose increase warrants stepping back to the previous dose for 2 to 4 additional weeks before trying again